Efficacy of recombinant human GM-CSF compared to placebo for autoimmune pulmonary alveolar proteinosis: a systematic review and meta-analysis.

BMC Pulm Med · 2026 · PMC13040946 · PMID 41742124

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

did not reach statistical significanceP = 0.08so close (0.05 < p ≤ 0.1)

3 ) when compared to the controlled group (mean difference [MD] −4.99 mmHg; 95% CI −9.67 to-0.32; P = 0.04), whereas the malgramostim subgroup showed a similar magnitude of effect that did not reach statistical significance (MD −4.90 mmHg; 95% CI −10.30 to 0.50; P = 0.08).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.